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A 160kb minimal common region in Xp21 has been determined as the cause of XY gonadal dysgenesis, if duplicated. The region
contains the MAGEB genes and the NR0B1 gene; this is the candidate for gonadal dysgenesis if overexpressed. Most patients
present gonadal dysgenesis within a more complex phenotype. However, few independent cases have recently been described
presenting with isolated XY gonadal dysgenesis caused by relatively small NR0B1 locus duplications. We have identiﬁed another
NR0B1 duplication in two sisters with isolated XY gonadal dysgenesis with an X-linked inheritance pattern. We performed X-
inactivation studies in three fertile female carriers of three diﬀerent small NR0B1 locus duplications identiﬁed by our group. The
carrier mothers did not show obvious skewing of X-chromosome inactivation, suggesting that NR0B1 overexpression does not
impair ovarian function. We furthermore emphasize the importance to investigate the NR0B1 locus also in patients with isolated
XY gonadal dysgenesis.
1.Introduction
Xp21 duplications containing the NR0B1 (DAX1)l o c u sh a v e
long been known to be associated with XY gonadal dys-
genesis (GD). A 160-kb minimal common region that, if
duplicated, causes XY GD has also been determined [1]b y
comparing several patients with Xp rearrangements. This
minimal region contains the MAGEB genes and the NR0B1
(DAX1)g e n e ,w i t hNR0B1 as the strongest candidate to
cause gonadal dysgenesis if overexpressed [1, 2]. In fact
NR0B1 has an embryonic expression compatible with a
role in sex determination and in adrenal and hypothala-
m i cf u n c t i o ni nm i c e[ 3], and several functional roles in
the hypothalamic-pituitary-adrenal-gonadal axis have been
reported [4]. However, XY mice transgenic for Dax1 show
delayed testis development and sex reversal only if the
transgene is tested against a weak Sry allele [5]. In humans,
the eﬀect of NR0B1 overexpression is also shown by XY
patients with 1p duplications including the WNT4 gene;
WNT4 is a signalling molecule that has been shown to
upregulate NR0B1 and XY patients with WNT4 duplications
present with abnormal gonadal development [6]. Another
indirect proof in human patients is provided by patients
with XY GD caused by NR5A1 (SF1) haploinsuﬃciency.
NR0B1hasbeenreportedtoinhibitNR5A1,withconsequent
reduction of steroidogenesis and AMH production, thus it
can be hypothesized that overexpression of NR0B1 leads to
gonadal dysgenesis via inhibition of NR5A1.
Although the aforementioned data support NR0B1 as
the gene responsible for GD, a direct proof in a patient is
still missing as a duplication containing only the NR0B1
gene has not been identiﬁed yet in XY patients with GD.
All duplications reported so far also contain at least some of
the MAGEB genes that have speciﬁc testis expression but yet
unknown function; thus, they cannot be ignored.
Most patients reported before the development of array-
CGH had XY GD as part of a more complex phenotype2 International Journal of Endocrinology
which also included dysmorphic features and/or mental re-
tardation (forreview[7,8]).Thisisexplainedbythefactthat
most patients have been identiﬁed by conventional kary-
otyping; thus, they carry large genomic rearrangements
involving several genes.
We have previously described two NR0B1 locus duplica-
tions in three patients with isolated XY GD; two sisters with
complete XY GD [9] and a boy with partial XY GD [10].
Both duplications were of a relatively small size (≤800kb).
In fact they were not identiﬁed by conventional karyotyping
but by array-CGH and MLPA, respectively. This indicates
that NR0B1 locus duplications should be investigated also in
cases with isolated XY GD and not only when GD, in partial
or complete form, is part of a more complex phenotype. In
fact two other groups have applied array-CGH to patients
with 46,XY GD and have identiﬁed additional NR0B1 locus
duplications [11, 12].
We developed a DSD probe set for MLPA analysis to
screen for dosage imbalances of several genes involved in
DSD, with particular attention to genes involved in GD
[10]. This probe set includes probes for NR0B1 and also the
MAGEB1 gene, thus enabling us to detect small NR0B1 locus
duplications. Here, we present a NR0B1 locus duplication
responsible for isolated XY GD identiﬁed in a large English
family. We also analysed the X-inactivation patterns in fertile
female carriers of each of the three small NR0B1 locus
duplications identiﬁed by our group. Female carriers of
macroscopic Xp21 duplications are thought to be healthy
and fertile due to skewed X-inactivation, preferentially inac-
tivating the duplicated chromosome and thereby protecting
the individual from increased gene expression. Similarly,
a skewed inactivation in carriers of the small duplications
would indicate a deleterious eﬀect on increased NR0B1
(DAX1) gene expression on ovarian function.
2.MaterialsandMethods
2.1. Patients. We studied an English family (Figure 1)w i t h
two sisters with isolated 46,XY GD. An X-linked inheritance
of the defect was suspected on the basis that, through the
maternal line, there is a relative who is an XY female.
Informed consent and ethical approval were obtained.
Patient VI.1 (proband) presented with primary amenor-
rhea at 16 years of age. She had female external genitalia. The
endocrine proﬁle showed markedly elevated gonadotropins
and low oestradiol. The testosterone level was 1nmol/L
and androstenedione was 2.4nmol/L. Chromosomal exam-
ination and revealed a 46,XY karyotype. At ultrasound
examination and the vagina was normal with a small
prepubertal uterus of 1.8mL of volume. A small amount of
tissue of 0.5mL volume was visible in the region of the right
gonad,nofollicleswereidentiﬁedwithinit.Noovariantissue
was identiﬁed on the leftside; however, this may be due to
technical problem rather than the gonad being absent. At
17 years and 5 months of age, she underwent gonadectomy.
Histological examination revealed fallopian tubes, and streak
gonads. Ovarian-type stroma could be detected, and in one
area some follicle cells could be demonstrated.
Carrier
Potential carrier
VI
V
IV
III
II
I
1 23 4
12
12
1 2
12
1 2
3 4
34
56
3456
34567
XY
XY
XY XY
XX
XX
+DAX1
+DAX1 +DAX1
Figure 1: Family pedigree. Pedigree of a family with two sisters
with 46,XY gonadal dysgenesis. +DAX1 indicates the subjects that
carry the X chromosome containing the NR0B1 locus duplication.
XX and XY have been added underneath some subjects indicating a
46,XX or 46,XY karyotype, respectively. Mandatory female carriers
and potential carriers are marked.
Patient VI.3 is the younger sister of patient I1. She also
had a 46,XY karyotype. Ultrasound examination, at 12 years
and 4 months of age, revealed a prepubertal uterus, the
right gonad had a 0.2mL volume, while no left gonad was
seen.Histologicalexaminationaftergonadectomyat12years
and 11 months of age showed the presence of unremarkable
fallopian tubes, ovarian stroma cells, and gonadoblastoma,
bilaterally.
Subject VI.2 has a 46,XX karyotype, she is an adult, and
at the moment she does not wish to know if she is a carrier
or not. After genetic counselling, no genetic investigation has
been performed for this subject.
Patient VI.4 is a female with a 46,XY karyotype; however,
no more information is available. No genetic investigation
was performed as DNA was not available. It is very likely that
she carries the same genetic defect as patient I1 and I3.
2.2. DNA. DNA was extracted from blood and/or Epstein-
Barr virus-immortalized cell lines by phenol/chloroform ex-
traction.
2.3. MLPA Analysis. For the initial MLPA analysis, the in-
house designed synthetic probe set DSD together with
the EK1 reagent kit from MRC Holland (Amsterdam, The
Nederland) was used as previously described [10]. Several
probe mixes (Table 1)w i t hd i ﬀerent combinations of probes
targeting sequences within the Xp21 region were used to
further narrow down the breakpoint regions.
2.4. Fluorescence In Situ Hybridization. Fluorescence in situ
hybridization (FISH) analysis on metaphase nuclei prepared
from EBV-immortalized lymphocytes was performed as
previously described [9], using the BAC clone RP11-662D2International Journal of Endocrinology 3
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which contains the NR0B1 gene.
2.5. X-Inactivation Experiments. The X-inactivation pattern
was examined by the methylation analysis of the polymor-
phic CAG repeat within the androgen receptor gene [13].
Brieﬂy, 250ng of DNA were digested using the methylation
sensitive enzyme HpaI; digested and undigested DNA sam-
ples were ampliﬁed by PCR using a primer pair ﬂanking the
CAG repeat region as well the cleavage site, with the forward
primer FAM labelled, Taq Gold (Applied Biosystems), 1X
buﬀer II (Applied Biosystems), 200µMo fe a c hd N T P s ,
and 1.5mM MgCl2. PCR products, together with the ROX
HD400 size marker (Applied Biosystems), were size sepa-
rated by capillary electrophoresis using a ABI3100 genetic
analyser (Applied Biosystems, Warrington,UK). Trace data
were analysed using the GeneMapper software (Applied
Biosystems). Peak heights for the two digested alleles were
corrected by the peak heights of the corresponding undi-
gested alleles. The ratios of the skewed X-inactivation in
digested samples were calculated by normalizing the sum of
the two corrected alleles to 100%. DNA was obtained from
EBV-immortalized cell line and from blood. In addition,
DNA from a male sample was included as control for
completedigestion.Dataarepresentedastheaverageofthree
independent experiments.
3. Results
3.1. MLPA Detection and Fine Mapping of the Duplication.
T h eM L P Aa n a l y s i sw i t ht h eD S Dp r o b es e td e t e c t e da
duplication of the DAX1 probe as well of the MAGEB1last
probe, targeting the last exon of the MAGEB1 gene, in both
aﬀected sisters. MLPA was also used to further characterize
the breakpoint region, using several probe mixes with diﬀer-
ent combination of probes targeting the Xp21 locus. We
determined that the telomeric breakpoint region (5.6kb)
is located approximately 63kb upstream of the MAGEB
genes, while the centromeric breakpoint region (2.6kb) lies
within intron 11 of the MAP3K7IP3 gene. Thus, the dup-
lication has a minimal and maximal size of 679kb and
687kb, respectively, and in addition to NR0B1 it contains the
MAGEB genes, CXorf21, GK and part of the 3  region of the
MAP3K7IP3 gene (Figure 2).
Parental DNA analysis revealed that the mother is a
healthy carrier of the duplication. Table 1 summarizes all
the probe pairs used and the results obtained. Together with
theseEnglishpatients,wepresent,forcomparison,theresults
obtained for two Iranian sisters [9] and for an Italian pa-
tient, in which we previously narrowed down the breakpoint
region [10].
3.2. Analysis of the Duplication Using FISH. Metaphase FISH
analysis was performed to establish the location of the extra
copy. On metaphases from the patient, only one signal
for the clone RP11-662D2 containing the NR0B1 gene was
detected;onmetaphasesfromthemotheronlyonesignalper
X chromosome was detected, thus indicating an interstitial
duplication and excluding translocation of X chromosome
material onto another chromosome (data not shown).
3.3. X-Inactivation Studies. We analysed the X-inactivation
pattern in subject V-1, and the methylation ratio between
the X-chromosome carrying the duplication and the nor-
mal chromosome, in EBV-immortalized lymphocytes, was
65%:35%. We performed X-inactivation studies also on two
other mothers carrying diﬀerent NR0B1 locus duplication
that have been previously described by our group [9, 10].
Ratios between the X-chromosome carrying the duplica-
tion and the normal chromosome were 58%:42% and
33%:67%, respectively.
These results indicate that in lymphocytes there is not a
strong preferential methylation for the X-chromosome car-
rying the duplication.
4. Discussion
We present here a family where a relatively small NR0B1
locus duplication is the genetic cause of isolated complete
46,XY GD. The duplication extends from the MAGEB gene
to part of the MAP3K7IP3 gene, including NR0B1, CXorf21,
and GK genes.
By bioinformatics evaluation of the breakpoint regions,
we noted that within the telomeric breakpoint region there is
a AluSc repeat of approximately 300bp that shares 85% and
84% identity (BLASTN2.2.21 [14]) with two AluY repeats
withinintron11oftheMAP3K7IP3gene.Theseevolutionary
young Alu repeats may be involved in the duplication
mechanism as they are found to be enriched near or within
duplication junction [15]. We unfortunately have not been
able to amplify and sequence the duplication junction so we
could not determine the rearrangement mechanism and dif-
ferentiate between a nonallelic homologous recombination
(NAHR) or a nonhomologous end joining (NHEJ) mech-
anism. The latter was the mechanism of the duplication in
a previously described family [9]. Actually, the failure, after
several attempts, to amplify the duplication junction in two
of the three duplications we have identiﬁed, makes us sus-
pect that the duplications could be more complex and be
generated by a FoSTes (Fork Stalling and Template Switch-
ing).
Xp21 duplications, as well deletions [16], including the
NR0B1 gene, are all diﬀerent, thus they are caused by non-
recurrent rearrangements. This indicates that in this region
there are several genomic elements that can lead to genomic
rearrangements. These rearrangements will be diﬀerent
regarding size and genes involved. This is important to
consider when a genetic test is chosen or developed to screen
for these genomic disorders.
Two other groups have applied array-CGH to analyse
patientswith46,XYgonadaldysgenesis andfoundadditional
Xp21 duplications [11, 12]. Patients with large duplications
presented XY gonadal dysgenesis associated to syndromic
feature, while two patients with relatively smaller duplica-
tions (<1Mb) including NR0B1 presented isolated 46,XY
gonadaldysgenesis(Figure 2).Thus,conﬁrmingourﬁndings6 International Journal of Endocrinology
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Figure 2: Comparison of NR0B1 locus duplications. Representation from the UCSC genome browser (NCBI36/hg18) of the NR0B1 locus
on Xp21.2. The probes that delineate the breakpoints in the three independent families identiﬁed by our group are represented by red
vertical lines. The horizontal blue line represents the extension of the duplication in the family here described, the green lines represent the
duplicatedregionspreviouslydescribedbyourgroup,andtheorangelinesrepresentthetwoduplicationsidentiﬁedbyarrayCGHinpatients
with isolate 46,XY GD by other groups. The C and P at the right ends of the lines indicate if the GD was complete or partial, respectively.
that NR0B1 locus duplication should be investigated in all
cases of isolated 46,XY gonadal dysgenesis.
By comparing the three small Xp21.2 duplications iden-
tiﬁed by our group, together with the other two recently
reported by Ledig et al. and White et al. [11, 12]( Figure 2),
it is not possible to directly delineate a genotype-phenotype
correlation for the partial or complete GD forms. It is known
that dosage-sensitive genes with complex expression patterns
are particularly sensitive to positional eﬀects, and regulatory
regions can lie far outside the transcription unit [17]. A
regulatory region upstream NR0B1 has been proposed after
the identiﬁcation of a 257kb deletion in the region be-
tween NR0B1 and GK gene in a patient with XY GD [18].
Furthermore, a small inversion immediately upstream of
NR0B1 has been identiﬁed in a patient with congenital
adrenal hypoplasia [19]. However, patients with both partial
andcompleteformshareentirelytheseregionsintheirdupli-
cations. The interaction of NR0B1 with other transcription
factors could also modulate the ﬁnal phenotype.
Interestingly, in all cases with isolated 46,XY GD, the
IL1RAPL1 gene, located immediately telomeric to the dup-
lication containing NR0B1, is not disrupted (Figure 2). Dele-
tions or mutations of this gene have been identiﬁed in pa-
tients with mental retardation [20]. Disruption of this gene
could explain the mental retardation in some previously
described patients with larger Xp21 duplications.
As all three duplications we identiﬁed were maternally
inherited, we could use the material available to investigate
the X-inactivation pattern of the duplicated X. In several
studies where a larger Xp21 duplication was maternally
inherited, it was shown that the duplicated X was preferen-
tially inactivated [21, 22]. Thus carrier women are thought
to be protected from a double NR0B1 dose on the gene
expression level. Therefore, we investigated if there was a
preferential methylation of the duplicated X chromosome
alsoin femalescarrying thesmallduplications whichcontain
fewer deleterious genes. Analysis in lymphocytes of the
three mothers showed that there is no obvious preferential
inactivation of the duplicated X. Even though we could
not investigate the situation directly in the ovary, we can
hypothesize that healthy carrier women are fertile because
the ovary, in contrast to the testis, can tolerate an extra dose
of NR0B1.
In conclusion, the identiﬁcation of NR0B1 locus dupli-
cations in patients/families, originating from diﬀerent coun-
tries (Iran [9], Italy [10], England (this study), Germany
[11], and Australia [12] stresses the importance of using
methods that can detect submicroscopic duplications of the
region surrounding NR0B1 in the evaluation of patients with
isolated 46,XY GD (complete or partial). The lack of pheno-
type in the carrier mothers and the pedigree of the family
here described also illustrate that such duplications can beInternational Journal of Endocrinology 7
spread through the female line in the family. In the present
family there are seven mandatory female carriers and nine
potential carriers. In fact, some of these could even be
aﬀected XY females who have not been investigated. Small
duplications are most probably more frequent, but have
escaped detection due to the methods that have been used
so far and the selection of the patients investigated. We
believe that in a patient with isolated XY GD, the NR0B1
locusshouldbecarefullyinvestigated.MLPAandarray-CGH
are two diﬀerent techniques that can be applied. Array-
CGH oﬀers the advantage of a whole genome screening
approach; however, the capacity to detect very small NR0B1
duplications depends on the platform used (number and
distance of probes within the NR0B1 locus). NR0B1 has a
size of 5kb, and the two nearest AluSx sequences on opposite
sideofNR0B1areonly14kbapart.MLPAcontainingspeciﬁc
probes guarantees the identiﬁcation, of isolated NR0B1
duplications and the maternal sample can be simultaneously
analysed for carrier status at a limited extra cost compared to
array CGH.
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